HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robert L Avery Selected Research
Robert L Avery Research Topics
Disease
12
Macular Degeneration (Age-Related Maculopathy)
01/2022 - 03/2006
9
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 10/2006
9
Macular Edema
10/2017 - 03/2006
4
Retinal Vein Occlusion
10/2017 - 04/2007
3
Choroidal Neovascularization
08/2019 - 03/2006
3
Endophthalmitis (Ophthalmia)
12/2014 - 11/2006
2
Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2020 - 02/2012
2
Blindness (Hysterical Blindness)
07/2020 - 01/2018
2
Inflammation (Inflammations)
04/2019 - 02/2007
2
Diabetes Mellitus
04/2017 - 10/2006
2
Epiretinal Membrane (Epiretinal Membranes)
04/2017 - 09/2007
2
Edema (Dropsy)
12/2016 - 06/2011
2
Retinal Perforations
06/2015 - 09/2011
2
Retinal Detachment (Retinal Detachments)
01/2015 - 06/2004
2
Hemorrhage
06/2011 - 02/2007
2
Retinal Hemorrhage
10/2008 - 02/2007
1
Geographic Atrophy
01/2022
1
Ischemia
01/2022
1
Hypoxia (Hypoxemia)
01/2022
1
Hyperglycemia
01/2019
1
Hypertension (High Blood Pressure)
12/2016
1
Stroke (Strokes)
01/2016
1
Myocardial Infarction
01/2016
1
Vascular Diseases (Vascular Disease)
01/2016
1
Open-Angle Glaucoma (Glaucoma, Open Angle)
04/2015
1
Ocular Hypertension (Glaucoma, Suspect)
04/2015
1
Infections
12/2014
1
Retinal Diseases
06/2014
1
Pain (Aches)
11/2013
1
Proliferative Vitreoretinopathy
09/2007
1
Papilledema
02/2007
1
Brain Edema (Cerebral Edema)
02/2007
1
Pathologic Neovascularization
11/2006
1
Uveitis
11/2006
1
Anterior Uveitis
09/2006
1
Hyperoxia
06/2004
Drug/Important Bio-Agent (IBA)
12
Bevacizumab (Avastin)
FDA Link
10/2017 - 03/2006
11
Ranibizumab (Lucentis)
FDA Link
08/2019 - 11/2006
8
Retinaldehyde (Retinal)
IBA
01/2022 - 10/2006
8
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2020 - 11/2006
5
aflibercept
IBA
08/2019 - 12/2014
3
Fluorescein (Funduscein)
FDA Link
Generic
10/2013 - 10/2006
3
Biological Products
IBA
10/2008 - 03/2006
2
parylene
IBA
12/2021 - 01/2018
2
microplasmin
IBA
04/2017 - 06/2015
2
Pharmaceutical Preparations
IBA
10/2013 - 02/2012
2
Vimentin
IBA
09/2007 - 06/2004
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
01/2019
1
Cytokines
IBA
01/2019
1
Glucose (Dextrose)
FDA Link
Generic
01/2019
1
Retinol-Binding Proteins (Retinoid Binding Proteins)
IBA
01/2019
1
Retinal Pigments (Pigments, Visual)
IBA
01/2018
1
Lipids
IBA
12/2016
1
hydroxide ion
IBA
04/2015
1
Glucocorticoids
IBA
04/2015
1
Mucins
IBA
04/2015
1
Steroids
IBA
04/2015
1
Aerosolized Particles and Droplets
IBA
12/2014
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2014
1
Antibodies
IBA
09/2007
1
Glial Fibrillary Acidic Protein
IBA
09/2007
1
Laminin (Merosin)
IBA
09/2007
1
Neurofilament Proteins
IBA
09/2007
1
Bradykinin Receptors (Bradykinin Receptor)
IBA
02/2007
1
Prekallikrein
IBA
02/2007
1
Kallikreins (Kallikrein)
IBA
02/2007
1
Proteins (Proteins, Gene)
FDA Link
02/2007
1
Complement C1 (Complement 1)
IBA
02/2007
1
Proteome
IBA
02/2007
1
Carbonic Anhydrase I
IBA
02/2007
1
Neutralizing Antibodies
IBA
02/2007
1
Intermediate Filament Proteins
IBA
06/2004
1
Oxygen (Dioxygen)
IBA
06/2004
Therapy/Procedure
3
Vitrectomy
04/2019 - 09/2007
3
Intravitreal Injections
04/2017 - 09/2006
3
Therapeutics
01/2016 - 06/2004
3
Injections
01/2016 - 10/2008
2
Traction
04/2017 - 06/2015
1
Glycemic Control
01/2019
1
Lasers (Laser)
12/2016
1
Light Coagulation
12/2016
1
Photochemotherapy (Photodynamic Therapy)
01/2012
1
Endotamponade
09/2011
1
Aftercare (After-Treatment)
06/2011